We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
(+22%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$124M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$95.2M |
| 3 |
Pliant Therapeutics
PLRX
|
+$74.8M |
| 4 |
Microsoft
MSFT
|
+$72.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$56.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$123M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$60.4M |
| 3 |
Emerson Electric
EMR
|
+$55M |
| 4 |
Home Depot
HD
|
+$54.8M |
| 5 |
Comcast
CMCSA
|
+$53.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.44% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Utilities | 1.38% |
| 5 | Industrials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Acumen Pharmaceuticals
ABOS
$176M
| $5.8M | 0.03% |
1,206,548
| – | – |
|
252
PUT
Devon Energy
DVN
$47.3B
| $5.6M | 0.03% |
115,900
+47,700
| +70% | +$2.4M |
|
253
CALL
ASML
ASML
$669B
| $5.58M | 0.03% |
7,700
-11,800
| -61% | -$8.02M |
|
254
Cummins
CMI
$88.7B
| $5.49M | 0.03% |
22,396
-3,493
| -13% | -$791K |
|
255
Netflix
NFLX
$309B
| $5.47M | 0.03% |
+124,190
| New | +$4.57M |
|
256
CALL
S&P Global
SPGI
$120B
| $5.45M | 0.03% |
13,600
-18,900
| -58% | -$6.91M |
|
257
lululemon athletica
LULU
$14.6B
| $5.36M | 0.03% |
14,174
+1,107
| +8% | +$408K |
|
258
Thermo Fisher Scientific
TMO
$220B
| $5.31M | 0.03% |
+10,169
| New | +$5.49M |
|
259
CALL
ConocoPhillips
COP
$141B
| $5.18M | 0.03% |
+50,000
| New | +$5.14M |
|
260
Starbucks
SBUX
$120B
| $5.14M | 0.03% |
+51,856
| New | +$5.38M |
|
261
PUT
First Solar
FSLR
$26.9B
| $4.9M | 0.03% |
25,800
-234,500
| -90% | -$46.5M |
|
262
Solid Biosciences
SLDB
$900M
| $4.86M | 0.03% |
928,169
| – | – |
|
263
Rallybio
RLYB
$85.8M
| $4.43M | 0.02% |
97,924
| – | – |
|
264
CALL
Uber
UBER
$153B
| $4.25M | 0.02% |
+98,500
| New | +$3.66M |
|
265
AnaptysBio
ANAB
$1.68B
| $4.25M | 0.02% |
209,002
-54,206
| -21% | -$1.1M |
|
|
266
PUT
ConocoPhillips
COP
$141B
| $4.22M | 0.02% |
+40,700
| New | +$4.18M |
|
267
Scholar Rock
SRRK
$6.44B
| $4.05M | 0.02% |
537,798
-15,902
| -3% | -$120K |
|
|
268
CALL
First Solar
FSLR
$26.9B
| $4.05M | 0.02% |
21,300
-205,700
| -91% | -$40.7M |
|
269
CALL
Lam Research
LRCX
$390B
| $3.99M | 0.02% |
62,000
-381,000
| -86% | -$21.5M |
|
270
CALL
ON Semiconductor
ON
$31.6B
| $3.94M | 0.02% |
+41,700
| New | +$3.45M |
|
271
Synopsys
SNPS
$79.7B
| $3.9M | 0.02% |
+8,968
| New | +$3.61M |
|
272
CALL
Workday
WDAY
$44.4B
| $3.84M | 0.02% |
+17,000
| New | +$3.41M |
|
|
273
PUT
Workday
WDAY
$44.4B
| $3.84M | 0.02% |
+17,000
| New | +$3.41M |
|
274
Cadence Design Systems
CDNS
$93.4B
| $3.83M | 0.02% |
+16,335
| New | +$3.56M |
|
275
UroGen Pharma
URGN
$2.29B
| $3.82M | 0.02% |
369,105
-11,495
| -3% | -$127K |
|
Similar funds
AFM
GCP
LCM
MAP
MA
LFM
NSAM
ABI
Laurion Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.
- Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
- Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
- Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
- Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
- Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
- Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
- Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.
Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.